Position in ZNTL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$264,714
+$14,955 QoQ
Shares Held
113,126
-38.9% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ZNTL ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $264,714 | 113,126 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $249,759 | 185,007 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,091,842 | 723,075 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $638,518 | 550,447 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,186,894 | 746,476 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,604,918 | 859,710 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,800,251 | 489,199 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $2,027,862 | 495,810 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $923,865 | 58,621 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,415,736 | 93,448 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,044,695 | 101,929 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,122,649 | 110,693 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,042,336 | 60,601 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $943,276 | 46,836 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $916,001 | 42,290 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,593,269 | 56,700 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,871,413 | 105,579 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,309,715 | 27,477 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,669,797 | 25,057 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,004,203 | 18,876 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $606,939 | 13,988 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $700,670 | 13,490 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $140,468 | 4,297 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $166,965 | 3,477 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||